Pipex Pharmaceuticals http://www.pipexpharma.com/ Pipex Pharmaceuticals News Releases Wed, 09 Jan 2008 17:33:00 GMT en-us Adeona Pharmaceuticals Announces Clinical Update and Third Quarter 2008 Results http://www.pipexpharma.com/investors.php?newsID=59 http://www.pipexpharma.com/investors.php?newsID=59 Wed, 09 Jan 2008 17:33:00 GMT Adeona Pharmaceuticals Announces Issuance Of US Patent For Oral Tiomolibdate Diammonium For Alzheimers Disease http://www.pipexpharma.com/investors.php?newsID=58 http://www.pipexpharma.com/investors.php?newsID=58 Wed, 09 Jan 2008 17:33:00 GMT Adeona Pharmaceuticals To Present At Rodman and Renshaw Healthcare Conference http://www.pipexpharma.com/investors.php?newsID=57 http://www.pipexpharma.com/investors.php?newsID=57 Wed, 09 Jan 2008 17:33:00 GMT Adeona Pharmaceuticals Oral dnaJP1 Phase II Clinical Findings Presented At The American College of Rheumatology Annual Meeting http://www.pipexpharma.com/investors.php?newsID=56 http://www.pipexpharma.com/investors.php?newsID=56 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals, Inc. Completes Corporate Name Change to Adeona Pharmaceuticals And Receives New Ticker Symbol http://www.pipexpharma.com/investors.php?newsID=55 http://www.pipexpharma.com/investors.php?newsID=55 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Oral Flupirtine Receives IRB Approval to Initiate Phase II Clinical Trial For Fibromyalgia http://www.pipexpharma.com/investors.php?newsID=54 http://www.pipexpharma.com/investors.php?newsID=54 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th http://www.pipexpharma.com/investors.php?newsID=53 http://www.pipexpharma.com/investors.php?newsID=53 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Oral TRIMESTA Phase IIa Clinical And Preclinical Findings Presented At World Congress On Treatment And Research In Multiple Sclerosis Meeting http://www.pipexpharma.com/investors.php?newsID=52 http://www.pipexpharma.com/investors.php?newsID=52 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis http://www.pipexpharma.com/investors.php?newsID=51 http://www.pipexpharma.com/investors.php?newsID=51 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results http://www.pipexpharma.com/investors.php?newsID=50 http://www.pipexpharma.com/investors.php?newsID=50 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Oral Zinthionein for Dry Age-Related Macular Degeneration (AMD) http://www.pipexpharma.com/investors.php?newsID=49 http://www.pipexpharma.com/investors.php?newsID=49 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer http://www.pipexpharma.com/investors.php?newsID=48 http://www.pipexpharma.com/investors.php?newsID=48 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Executes Option to License Oral Flupirtine Patent Estate for Diabetes, Diabetic Retinopathy, Retinitis Pigmentosa and Glaucoma http://www.pipexpharma.com/investors.php?newsID=47 http://www.pipexpharma.com/investors.php?newsID=47 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules http://www.pipexpharma.com/investors.php?newsID=46 http://www.pipexpharma.com/investors.php?newsID=46 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results http://www.pipexpharma.com/investors.php?newsID=45 http://www.pipexpharma.com/investors.php?newsID=45 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals To Provide Clinical Update and Report First Quarter http://www.pipexpharma.com/investors.php?newsID=44 http://www.pipexpharma.com/investors.php?newsID=44 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Receives FDA Orphan Drug Designation For Oral TTM For Idiopathic Pulmonary Fibrosis (IPF) http://www.pipexpharma.com/investors.php?newsID=43 http://www.pipexpharma.com/investors.php?newsID=43 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimers Disease http://www.pipexpharma.com/investors.php?newsID=42 http://www.pipexpharma.com/investors.php?newsID=42 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Oral Flupirtine Receives IND with FDA For Phase II Clinical Trial For Fibromyalgia http://www.pipexpharma.com/investors.php?newsID=39 http://www.pipexpharma.com/investors.php?newsID=39 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Fourth Quarter and Year End 2007 Results http://www.pipexpharma.com/investors.php?newsID=38 http://www.pipexpharma.com/investors.php?newsID=38 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Cost Reduction Measures http://www.pipexpharma.com/investors.php?newsID=36 http://www.pipexpharma.com/investors.php?newsID=36 Wed, 09 Jan 2008 17:33:00 GMT CORRECTION: Pipex Pharmaceuticals Oral Flupirtine IND With FDA for Phase II Clinical Trial for Fibromyalgia Not Yet Open http://www.pipexpharma.com/investors.php?newsID=37 http://www.pipexpharma.com/investors.php?newsID=37 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Completes Type A Meeting with FDA for Oral Tetrathiomolybdate New Drug Application http://www.pipexpharma.com/investors.php?newsID=34 http://www.pipexpharma.com/investors.php?newsID=34 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces First Notice Of Allowance For U.S. Patent Covering Uses Of Low Potency Bioidentical Estrogens for the Treatment Of Autoimmune Diseases of Women http://www.pipexpharma.com/investors.php?newsID=33 http://www.pipexpharma.com/investors.php?newsID=33 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application http://www.pipexpharma.com/investors.php?newsID=32 http://www.pipexpharma.com/investors.php?newsID=32 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Initiates Phase II Clinical Trial of Anti-Copper COPREXA for Alzheimers Disease http://www.pipexpharma.com/investors.php?newsID=31 http://www.pipexpharma.com/investors.php?newsID=31 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Files New Drug Application (NDA) with FDA to Market COPREXA for the Treatment of Initially Presenting Neurologic Wilsons Disease http://www.pipexpharma.com/investors.php?newsID=30 http://www.pipexpharma.com/investors.php?newsID=30 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces CRADA for Huntingtons Disease Development Program with Anti-Copper COPREXA http://www.pipexpharma.com/investors.php?newsID=29 http://www.pipexpharma.com/investors.php?newsID=29 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Receives $7.3 Million Through the Exercise of Warrants Issued in 2006 http://www.pipexpharma.com/investors.php?newsID=28 http://www.pipexpharma.com/investors.php?newsID=28 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals to Host Webcast to Discuss Results of Elevated Levels of Free Copper in Alzheimers Disease and Third Quarter 2007 Results http://www.pipexpharma.com/investors.php?newsID=27 http://www.pipexpharma.com/investors.php?newsID=27 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Test Confirms High Free Copper Levels in Alzheimers Disease Patients http://www.pipexpharma.com/investors.php?newsID=26 http://www.pipexpharma.com/investors.php?newsID=26 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Announces Participation in Acumen BioFin Rodman and Renshaw 9th Annual Healthcare Conference http://www.pipexpharma.com/investors.php?newsID=25 http://www.pipexpharma.com/investors.php?newsID=25 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Anti-Copper COPREXA Demonstrates 40% Reduction of Insoluble Amyloid Beta in Animal Models of Alzheimers Disease http://www.pipexpharma.com/investors.php?newsID=24 http://www.pipexpharma.com/investors.php?newsID=24 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Presents at International Society for Trace Element Research in Humans (ISTERH) Conference http://www.pipexpharma.com/investors.php?newsID=22 http://www.pipexpharma.com/investors.php?newsID=22 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Appoints David A. Newsome, M.D. as Chief Scientific Officer http://www.pipexpharma.com/investors.php?newsID=21 http://www.pipexpharma.com/investors.php?newsID=21 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Receives Equipment Loan from Bank of Ann Arbor http://www.pipexpharma.com/investors.php?newsID=20 http://www.pipexpharma.com/investors.php?newsID=20 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Files Pre-Investigational Device Exemption With FDA http://www.pipexpharma.com/investors.php?newsID=19 http://www.pipexpharma.com/investors.php?newsID=19 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceticals Present Announces Broadly Issued European Patent Covering Uses of Oral TRIMESTA for the Treatment of Autoimmune Diseases. http://www.pipexpharma.com/investors.php?newsID=18 http://www.pipexpharma.com/investors.php?newsID=18 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceticals Present At Nobel Financial Small Cap Conference. http://www.pipexpharma.com/investors.php?newsID=17 http://www.pipexpharma.com/investors.php?newsID=17 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceticals Announces Second Quarter 2007 Results. http://www.pipexpharma.com/investors.php?newsID=16 http://www.pipexpharma.com/investors.php?newsID=16 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Oral TRIMESTA Initiates Dosing in Phase II/III Clinical Trial For Multiple Scleros. http://www.pipexpharma.com/investors.php?newsID=15 http://www.pipexpharma.com/investors.php?newsID=15 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Oral TRIMESTA Initiates Enrollment of Phase II/III Clinical Trial for Multiple Sclerosis. http://www.pipexpharma.com/investors.php?newsID=12 http://www.pipexpharma.com/investors.php?newsID=12 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD) http://www.pipexpharma.com/investors.php?newsID=40 http://www.pipexpharma.com/investors.php?newsID=40 Wed, 09 Jan 2008 17:33:00 GMT American Stock Exchange lists the common stock of Pipex Pharmaceuticals. http://www.pipexpharma.com/investors.php?newsID=14 http://www.pipexpharma.com/investors.php?newsID=14 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals is Approved For Listing on the American Stock Exchange. Stock to Trade under New Ticker Symbol ‘PP. http://www.pipexpharma.com/investors.php?newsID=13 http://www.pipexpharma.com/investors.php?newsID=13 Wed, 09 Jan 2008 17:33:00 GMT Results Presented at the American Thoracic Society (ATS) Meeting. http://www.pipexpharma.com/investors.php?newsID=11 http://www.pipexpharma.com/investors.php?newsID=11 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals To Present At Acumen BioFin Rodman and Renshaw 4th Annual Global Healthcare Conference http://www.pipexpharma.com/investors.php?newsID=10 http://www.pipexpharma.com/investors.php?newsID=10 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice President of Manufacturing. http://www.pipexpharma.com/investors.php?newsID=9 http://www.pipexpharma.com/investors.php?newsID=9 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals, Inc. Announces the Appointment of Daniel J. Dorman and James S. Kuo,M.D., M.B.A. to the Board of Directors. http://www.pipexpharma.com/investors.php?newsID=8 http://www.pipexpharma.com/investors.php?newsID=8 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals COPREXA™ awarded $306,172 NIH Grant for Preclinical Testing in Alzheimers Disease. http://www.pipexpharma.com/investors.php?newsID=7 http://www.pipexpharma.com/investors.php?newsID=7 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceticals Audit Committee Charter. http://www.pipexpharma.com/investors.php?newsID=6 http://www.pipexpharma.com/investors.php?newsID=6 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals, Inc. Completes Corporate Name Change and New Ticker Symbol. http://www.pipexpharma.com/investors.php?newsID=5 http://www.pipexpharma.com/investors.php?newsID=5 Wed, 09 Jan 2008 17:33:00 GMT Pipex Pharmaceuticals Completes $13.7 Million in Private Equity Financings. http://www.pipexpharma.com/investors.php?newsID=4 http://www.pipexpharma.com/investors.php?newsID=4 Wed, 09 Jan 2008 17:33:00 GMT Pipex Therapeutics Receives Research Equipment Award from the State of Michigan and SPARK Foundation. http://www.pipexpharma.com/investors.php?newsID=3 http://www.pipexpharma.com/investors.php?newsID=3 Wed, 09 Jan 2008 17:33:00 GMT Pipex Therapeutics COPREXAandtrade; Pivotal Clinical Trial Results Presented at NIH-Sponsored Wilsons Disease Association Conference. http://www.pipexpharma.com/investors.php?newsID=2 http://www.pipexpharma.com/investors.php?newsID=2 Wed, 09 Jan 2008 17:33:00 GMT Pipex Therapeutics Merges with Sheffield Pharmaceuticals http://www.pipexpharma.com/investors.php?newsID=1 http://www.pipexpharma.com/investors.php?newsID=1 Wed, 09 Jan 2008 17:33:00 GMT